Imax price target raised to $26 from $24 at Wedbush

Wedbush analyst Michael Pachter raised the firm’s price target on Imax to $26 from $24 and keeps an Outperform rating on the shares. The firm notes Imax remains on Wedbush’s Best Ideas List, given its view that Imax is gaining market share as moviegoers increasingly prefer IMAX screens, significantly expanding its filmed-for-Imax partnerships, which should drive incremental market share gains in 2025, diversifying with more alternative content to boost revenue further, expanding its footprint globally and leaning into local-language content, and as it is poised to surpass peak EBITDA margins in the next three years.